V31-1 CANNT Journal Continuing Education Series Quiz

2.0 CLU

Please note: This quiz is for non-members only. CANNT members, please complete this course on your course dashboard https://cannt-acitn.ca/course-dashboard/. You must receive a score of 80% or higher to receive your CL credits. You will receive a certificate by email upon successful completion of the quiz. Please keep this email for your records.

V31-1 Non-member CE Quiz

  • Patients should have phosphorous targeted to appropriate levels based on degree of renal impairment for the following reasons:
  • 63-year-old female (dialysis vintage 3 years) with normocalcemia; hyperphosphatemia. Renal dietician has assessed and would prefer not to restrict diet d/t limited intake. Currently on lanthanum 500 mg tid. Patient unable to increase d/t constipation at higher doses. PMHx does not reveal any significant GI disorders. Patient pays for meds out-of-pocket. Most appropriate course of action for treating CKD-MBD includes:
  • 55-year-old male (dialysis vintage 1 year) with Hx failed renal transplant 10 yrs ago on mycophenolate mofetil 500 mg bid. Mildly low calcium; hyperphosphatemia. Other blood work of note includes Hgb 94. TSAT 15%. Ferritin 250. Patient has private drug coverage. BEST option for treatment:
  • 70-year-old female (dialysis vintage 3 years) on pantoprazole 40 mg bid (Zollinger-Ellison syndrome) with hypercalcemia; hyperphosphatemia. Also has PMHx bowel perforation. BEST option for treatment:
  • 85-year-old male (dialysis vintage 10 years) with hyperphosphatemia; normocalcemia. Patient is unable to swallow tablets whole. Relevant PMHx includes calciphylaxis (approx. 14 mos ago; now in remission) and chronic constipation.
  • In comparing sucroferric oxyhydroxide to sevelamer hydrochloride (Renagel™) in clinical trials, Velphoro™:
  • Which phosphate binder(s) are indicated in treatment of hyperphosphatemia in pre-dialysis patients?
  • Appropriate counselling point(s) for Velphoro™ include:
  • 9. Which of the following statements is TRUE:
  • 49-year-old male (dialysis vintage 8 years) with hyperphosphatemia requiring treatment. Patient also has GI disease, metabolic acidosis, and hypercalcemia. Most appropriate treatment option: